Literature DB >> 27565576

Functional exhaustion of CD4+ T cells induced by co-stimulatory signals from myeloid leukaemia cells.

Didem Ozkazanc1, Digdem Yoyen-Ermis1, Ece Tavukcuoglu1, Yahya Buyukasik2, Gunes Esendagli3.   

Abstract

To cope with immune responses, tumour cells implement elaborate strategies such as adaptive resistance and induction of T-cell exhaustion. T-cell exhaustion has been identified as a state of hyporesponsiveness that arises under continuous antigenic stimulus. Nevertheless, contribution of co-stimulatory molecules to T-cell exhaustion in cancer remains to be better defined. This study explores the role of myeloid leukaemia-derived co-stimulatory signals on CD4+ T helper (Th) cell exhaustion, which may limit anti-tumour immunity. Here, CD86 and inducible T-cell co-stimulator ligand (ICOS-LG) co-stimulatory molecules that are found on myeloid leukaemia cells supported Th cell activation and proliferation. However, under continuous stimulation, T cells co-cultured with leukaemia cells, but not with peripheral blood monocytes, became functionally exhausted. These in vitro-generated exhausted Th cells were defined by up-regulation of programmed cell death 1 (PD-1), cytotoxic T-lymphocyte antigen 4 (CTLA-4), lymphocyte activation gene 3 (LAG3) and T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) inhibitory receptors. They were reluctant to proliferate upon re-stimulation and produced reduced amounts of interleukin-2 (IL-2), tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ). Nonetheless, IL-2 supplementation restored the proliferation capacity of the exhausted Th cells. When the co-stimulation supplied by the myeloid leukaemia cells were blocked, the amount of exhausted Th cells was significantly decreased. Moreover, in the bone marrow aspirates from patients with acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS), a subpopulation of Th cells expressing PD-1, TIM-3 and/or LAG3 was identified together with CD86+ and/or ICOS-LG+ myeloid blasts. Collectively, co-stimulatory signals derived from myeloid leukaemia cells possess the capacity to facilitate functional exhaustion in Th cells.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  T-cell immunoglobulin and mucin domain-containing protein-3; cancer; helper T cell; immune escape; interleukin-2; lymphocyte activation gene 3; programmed cell death 1

Mesh:

Substances:

Year:  2016        PMID: 27565576      PMCID: PMC5095494          DOI: 10.1111/imm.12665

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

1.  Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cells.

Authors:  Andrew D Kaiser; Kerstin Schuster; Jules Gadiot; Lisa Borkner; Henry Daebritz; Clemens Schmitt; Reinhard Andreesen; Christian Blank
Journal:  Eur J Immunol       Date:  2012-01-23       Impact factor: 5.532

Review 2.  Adaptive Immune Resistance: How Cancer Protects from Immune Attack.

Authors:  Antoni Ribas
Journal:  Cancer Discov       Date:  2015-08-13       Impact factor: 39.397

3.  Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells.

Authors:  Nicola Gagliani; Chiara F Magnani; Samuel Huber; Monica E Gianolini; Mauro Pala; Paula Licona-Limon; Binggege Guo; De'Broski R Herbert; Alessandro Bulfone; Filippo Trentini; Clelia Di Serio; Rosa Bacchetta; Marco Andreani; Leonie Brockmann; Silvia Gregori; Richard A Flavell; Maria-Grazia Roncarolo
Journal:  Nat Med       Date:  2013-04-28       Impact factor: 53.440

Review 4.  Natural innate and adaptive immunity to cancer.

Authors:  Matthew D Vesely; Michael H Kershaw; Robert D Schreiber; Mark J Smyth
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

Review 5.  The B7 family and cancer therapy: costimulation and coinhibition.

Authors:  Xingxing Zang; James P Allison
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

6.  Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression.

Authors:  Sabine Mumprecht; Christian Schürch; Juerg Schwaller; Max Solenthaler; Adrian F Ochsenbein
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

7.  Myeloid leukemia cells with a B7-2(+) subpopulation provoke Th-cell responses and become immuno-suppressive through the modulation of B7 ligands.

Authors:  Yusuf Dolen; Gunes Esendagli
Journal:  Eur J Immunol       Date:  2013-01-31       Impact factor: 5.532

8.  The expression of co-stimulatory molecules and their relationship to the prognosis of human acute myeloid leukaemia: poor prognosis of B7-2-positive leukaemia.

Authors:  A Maeda; K Yamamoto; K Yamashita; K Asagoe; M Nohgawa; K Kita; H Iwasaki; T Ueda; A Takahashi; M Sasada
Journal:  Br J Haematol       Date:  1998-09       Impact factor: 6.998

9.  TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells.

Authors:  Valentina Folgiero; Loredana Cifaldi; Giuseppina Li Pira; Bianca Maria Goffredo; Luciana Vinti; Franco Locatelli
Journal:  J Hematol Oncol       Date:  2015-04-16       Impact factor: 17.388

10.  Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells.

Authors:  Sarah E Church; Shawn M Jensen; Paul A Antony; Nicholas P Restifo; Bernard A Fox
Journal:  Eur J Immunol       Date:  2013-11-21       Impact factor: 5.532

View more
  23 in total

Review 1.  Immune checkpoint-based therapy in myeloid malignancies: a promise yet to be fulfilled.

Authors:  Jan Philipp Bewersdorf; Maximilian Stahl; Amer M Zeidan
Journal:  Expert Rev Anticancer Ther       Date:  2019-03-19       Impact factor: 4.512

2.  Implications of Immune Checkpoint Expression During Aging in HIV-Infected People on Antiretroviral Therapy.

Authors:  Lesley R de Armas; Suresh Pallikkuth; Stefano Rinaldi; Rajendra Pahwa; Savita Pahwa
Journal:  AIDS Res Hum Retroviruses       Date:  2019 Nov/Dec       Impact factor: 2.205

3.  An inflammatory response-related gene signature associated with immune status and prognosis of acute myeloid leukemia.

Authors:  Xin Wu; Shiqin Li; Dongjie Chen; Guiping Zheng; Zhaohua Zhang; Zian Li; Xiaoying Sun; Qiangqiang Zhao; Jingjuan Xu
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

4.  Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma.

Authors:  Pingyan Cheng; Xianghong Chen; Robert Dalton; Alexandra Calescibetta; Tina So; Danielle Gilvary; Grace Ward; Victoria Smith; Sterling Eckard; Judith A Fox; Jeanmarie Guenot; Joseph Markowitz; John L Cleveland; Kenneth L Wright; Alan F List; Sheng Wei; Erika A Eksioglu
Journal:  Mol Ther       Date:  2022-02-09       Impact factor: 12.910

5.  Leukemia cell-derived microvesicles induce T cell exhaustion via miRNA delivery.

Authors:  Jieke Cui; Qing Li; Mei Luo; Zhaodong Zhong; Shu Zhou; Lin Jiang; Na Shen; Zhe Geng; Hui Cheng; Li Meng; Shujuan Yi; Hui Sun; Feifei Wu; Zunmin Zhu; Ping Zou; Yong You; An-Yuan Guo; Xiaojian Zhu
Journal:  Oncoimmunology       Date:  2018-03-26       Impact factor: 8.110

Review 6.  Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment.

Authors:  Yangjing Zhao; Qixiang Shao; Guangyong Peng
Journal:  Cell Mol Immunol       Date:  2019-12-18       Impact factor: 11.530

7.  Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with de novo acute myeloid leukemia.

Authors:  Jiaxiong Tan; Shaohua Chen; Yuhong Lu; Danlin Yao; Ling Xu; Yikai Zhang; Lijian Yang; Jie Chen; Jing Lai; Zhi Yu; Kanger Zhu; Yangqiu Li
Journal:  Chin J Cancer Res       Date:  2017-10       Impact factor: 5.087

Review 8.  CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

Authors:  Alexandra M Miggelbrink; Joshua D Jackson; Selena J Lorrey; Ethan S Srinivasan; Jessica Waibl-Polania; Daniel S Wilkinson; Peter E Fecci
Journal:  Clin Cancer Res       Date:  2021-06-14       Impact factor: 12.531

9.  Assay and Isolation of Single Proliferating CD4+ Lymphocytes Using an Automated Microraft Array Platform.

Authors:  Cody A LaBelle; Raymond J Zhang; Paul M Armistead; Nancy L Allbritton
Journal:  IEEE Trans Biomed Eng       Date:  2019-11-26       Impact factor: 4.538

10.  Tumor-infiltrating CD4+ T cells in patients with gastric cancer.

Authors:  Long Yuan; Benling Xu; Peng Yuan; Jinxue Zhou; Peng Qin; Lu Han; Guangyu Chen; Zhenlei Wang; Zengci Run; Peng Zhao; Quanli Gao
Journal:  Cancer Cell Int       Date:  2017-12-02       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.